Types of partnerships

Our innovative funding solutions create win-win partnerships across the biopharma ecosystem.

Existing royalties

We buy existing royalties on approved or late-stage development therapies with strong proof-of-concept to provide flexible funding solutions that align with our partners’ goals.

Synthetic royalties

We acquire newly-created royalties on approved or late-stage development therapies with strong proof-of-concept and high commercial potential.

Launch & development capital

We offer additional funding in exchange for long-term payment streams.

Facilitating M&A

We provide support to biotechnology and global pharmaceutical companies by monetizing non-strategic passive royalties to reduce the net cost of an acquisition. We also provide capital through the purchase of synthetic royalties and supplemental funding.

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe